Padma Bhushan Award for Founders of Bharat Biotech’s COVID-19 Vaccine

Couple behind Bharat Biotech — India's first indigenous developed vaccine for COVID-19 has been awarded Padma Bhushan.

Padma Bhushan — the third-highest civilian award in the country has been awarded to the couple who were behind India's first indigenous COVID-19 vaccine.

The award for co-founders of the Hyderabad-based company — Dr. Krishna Ella and //Suchitra Ella, was announced on the eve of 73rd Republic Day.

Bharat Biotech To Intensify Debate on Vaccine Price
Bharat Biotech's pricing announcement of its COVID-19 vaccine named Covaxin may spark the debate on pricing as the critics have slammed the vaccine manufacturers for 'profiteering'.

Dr. Krishna Ella is the Chairman and Managing Director of the biotechnology company while his wife is Joint Managing Director. They will receive the award for distinguished service of high order in the field of trade and industry.

The Hyderabad-based firm rolled out the vaccine early last year and it has since been part of India's COVID vaccination program.

The vaccine maker developed Covaxin in collaboration with the Indian Council of Medical Research's National Institute of Virology (NIV).

Padma Awards 2019: President Honors the Achievers
Padma Awards 2019: President Ramnath Kovind presented 55 of the 112 Padma awards - a Padma Vibhushan, eight Padma Bhushan and 46 Padma Shri - to distinguished personalities from different fields including a doctor pair.

Krishna and Suchitra Ella founded Bharat Biotech in 1996. A gold medalist at university, Krishna Ella worked as a research faculty at the Medical University of South Carolina, Charleston after earning his PhD from the University of Wisconsin-Madison.

A research scientist in Molecular Biology, he believes that innovative technology in vaccine development is essential to solve public healthcare problems caused by infectious diseases. Under his leadership, Bharat Biotech has grown to become a global leader in the innovative vaccine.

Vaccine Maker Bharat Biotech Scales Up Manufacturing Of Covaxin
Bharat Biotech has scaled up the manufacturing capacity to produce about 700 million doses of its COVID-19 vaccine Covaxin annually.

A serial entrepreneur with a passion for innovative ideas, he has also ventured into veterinary vaccines, food processing, and developing biotechnology infrastructure in the country.

A BA in economics and social sciences from the University of Madras, Suchitra Ella holds diplomas in business development from UWCU, Madison, the US. She also holds a diploma in real estate management from the University of South Carolina, and a post-graduate diploma in patent law from NALSAR, Hyderabad.

Bharat Biotech to Make Antigen for Malaria Vaccine
Global healthcare company GSK, non-profit agency working to end health inequity PATH, and vaccine maker Bharat Biotech on Wednesday announced the signing of a product transfer agreement for malarial vaccine.

Meanwhile, five others from the Telugu states of Telangana and Andhra Pradesh figure in the list of Padma Shri awardees.

They include Narasimha Rao Garikapati (literature and education), Gosaveedu Shaik Hassan (posthumous) (art), Dr. Sunkara Venkata Adinarayana Rao (medicine) from Andhra Pradesh, Darshanam Mogilaiah, Ramachandraiah and Padmaja Reddy (Art) from Telangana.

Andhra Pradesh Chief Minister Y.S. Jagan Mohan Reddy has congratulated the Telugu people who were nominated for the Padma Awards for their efforts in their respective fields.

Telangana Chief Minister K. Chandrasekhar Rao has also congratulated Padma awardees from the state.

Source-IANS